论文部分内容阅读
目的探讨抗凝剂和血栓溶解药物积极治疗急性肺梗死的临床效果。方法随机抽取本院在2010年2月~2013年2月期间收治的80例急性肺梗死患者的临床资料进行回顾性分析,根据治疗方法的不同,将本组患者分为对照组和观察组,每组40例,对照组采用血栓溶解药物给予治疗,观察组采用抗凝剂和血栓溶解药物积极治疗,针对两组患者的治疗效果进行对比分可析,综合评价抗凝剂和血栓溶解药物积极治疗急性肺梗死临床效果。结果对照组治疗有效率为72.5%,观察组治疗有效率达97.5%,其治疗效果明显高于对照组,差异具有统计学意义(P<0.05)。结论采用抗凝剂和血栓溶解药物积极治疗急性肺梗死,疗效确切,安全可靠,值得临床推广与应用。
Objective To investigate the clinical effects of anticoagulants and thrombolytic drugs in active treatment of acute pulmonary infarction. Methods The clinical data of 80 patients with acute pulmonary infarction admitted in our hospital from February 2010 to February 2013 were retrospectively analyzed. According to the different treatment methods, the patients were divided into control group and observation group, Each group of 40 cases, the control group was treated with thrombolytic drugs, the observation group with active treatment of anticoagulants and thrombolytic drugs for the treatment of two groups of patients were analyzed scores, a comprehensive evaluation of anticoagulants and thrombolytic drugs positive Treatment of acute lung infarction clinical effect. Results The effective rate of the control group was 72.5%, and the effective rate of the observation group was 97.5%. The treatment effect was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Conclusion The treatment of acute pulmonary infarction with anticoagulants and thrombolytic drugs is effective and safe, which is worthy of clinical promotion and application.